Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retinoid effects on sebocyte proliferation.

T I Doran, S S Shapiro

    Methods in Enzymology
    |January 1, 1990
    PubMed
    Summary
    This summary is machine-generated.

    A novel human sebocyte model accurately predicts clinical efficacy for acne treatments, outperforming traditional animal models. This in vitro system shows retinoids like isotretinoin inhibit sebocyte proliferation, correlating with human acne treatment success.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Lupus anticoagulants and anticardiolipin antibodies: personal reminiscences, a little history, and some random thoughts.

    Journal of thrombosis and haemostasis : JTH·2005
    Same author

    Measurement of the solar gravitational deflection of radio waves using geodetic very-long-baseline interferometry data, 1979-1999.

    Physical review letters·2004
    Same author

    Anti-endothelial cell antibodies in Behçet's disease.

    Clinical and experimental rheumatology·2004
    Same author

    Role of vitamins in skin care.

    Nutrition (Burbank, Los Angeles County, Calif.)·2001
    Same author

    Mother-to-child transmission of the human immunodeficiency virus in Texas.

    The Pediatric infectious disease journal·2001
    Same author

    Evaluation of endothelial cell migration with a novel in vitro assay system.

    Methods in cell science : an official journal of the Society for In Vitro Biology·2001
    Same journal

    Clinical Europium fluorescent based lectin assays for mucin O-glycomics.

    Methods in enzymology·2026
    Same journal

    A dual-color FRET assay for detection and quantitative analysis of O-glycopeptidases.

    Methods in enzymology·2026
    Same journal

    Evolutionary genetic approaches to analyze mucins.

    Methods in enzymology·2026
    Same journal

    Ex vivo imaging and enzymatic analysis of intestinal mucus.

    Methods in enzymology·2026
    Same journal

    Glyco-TRAPP: A real-time glycocalyx permeability assay for assessing transmembrane mucin barrier function in live and fixed tissues.

    Methods in enzymology·2026
    Same journal

    Quantitative imaging approaches to capture structural and functional dynamics of colonic mucus in health and disease in situ.

    Methods in enzymology·2026
    See all related articles

    Area of Science:

    • Dermatology
    • In vitro modeling
    • Pharmacology

    Background:

    • Current animal models for evaluating acne treatments lack direct correlation with clinical outcomes.
    • Arotinoids, effective in animal models, do not always translate to clinical efficacy in human acne.
    • There is a need for more predictive in vitro models for acne drug development.

    Purpose of the Study:

    • To introduce and validate a human sebocyte model for assessing the clinical efficacy of acne treatments.
    • To compare the predictive power of the human sebocyte model against traditional animal models.

    Main Methods:

    • Utilized an in vitro human sebocyte model to study cellular responses to various retinoids.
    • Assessed parameters including cell proliferation ([3H]thymidine uptake), and synthesis of proteins and lipids.

    Related Experiment Videos

  • Compared the in vitro results with known clinical activity of compounds in human acne and psoriasis.

    • Main Results:

    • The human sebocyte model demonstrated that retinoids like isotretinoin and tretinoin inhibit sebocyte proliferation, aligning with their clinical activity in acne.
    • Sebocytes in this model were unresponsive to temarotene, an arotinoid active in animal models but not clinically in acne.
    • The model also showed no response to etretinate, effective in psoriasis but not acne.

    Conclusions:

    • The human sebocyte model offers superior prediction of clinical efficacy for acne treatments compared to animal models.
    • This in vitro system allows for the study of multiple cellular parameters relevant to sebaceous gland function and drug response.
    • The model's ability to differentiate between clinically active and inactive compounds highlights its potential in acne research and drug discovery.